22nd Century Group Inc
NASDAQ:XXII
| Market Cap (Intraday) | 393.99M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.66 |
| 50-Day MA | $2.70 |
| 200-Day MA | $3.47 |
22nd Century Group Inc Stock, NASDAQ:XXII
500 Seneca Street, Suite 507, Buffalo, New York 14204
United States of America
Phone: +1.716.270.1523
Number of Employees: 67
Description
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.